Dicks Sporting Goods Inc vs Neurocrine Biosciences Inc — how do they compare? Dicks Sporting Goods Inc trades at $203.21 (market cap $18.35B), while Neurocrine Biosciences Inc trades at $157.57 (market cap $16.46B). The key difference: Dicks Sporting Goods Inc and Neurocrine Biosciences Inc are close in size by market cap, and Dicks Sporting Goods Inc pays a 2.44% dividend while Neurocrine Biosciences Inc pays none. Which is the better fit depends on your goals.
| DKS | NBIX | |
|---|---|---|
Market Cap | $18.35B | $16.46B |
Sector | Consumer Cyclical | Health |
52-Week High | $239.17 | $185.50 |
52-Week Low | $187.78 | $123.10 |
Enterprise Value | $25.14B | $16.48B |
Dividend Yield | 2.44% | — |
Trailing returns across standard periods
Latest headlines on both assets
Dick's Sporting Goods is a leading omni-channel sporting goods retailer in the US It offers an extensive assortment of authentic sports equipment, apparel, footwear, and accessories through its stores and digital platforms.
Read more on DKS →Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →